FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshihiro Wakazono

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Physiology

Procedures

Remission Induction

Co-author Network

Publications

TOP 3
Katsutsugu Umeda; Makoto Yoshida; Nobuhiro Suzuki; Mikiya Endo; Atsushi Sato; Hiroki Hori; Mitsuharu Isogai; Kimikazu Matsumoto; Jun-iIchi Hara; Daiichiro Hasegawa; Yoshiko Hashii; Kosuke Chayama; Ryousuke Miyaji; Shin-ichiro Nishimura; Akihiko Tanizawa; Ikuya Uami; Keizo Horibe; Yoshihiro Wakazono; Keiko Yagi
[Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
Yoshiyuki Kosaka; Katsuyoshi Koh; Naoko Kinukawa; Yoshihiro Wakazono; Keiichi Isoyama; Takanori Oda; Yasuhide Hayashi; Shigeru Ohta; Hiroshi Moritake; Megumi Oda; Yoshihisa Nagatoshi; Hisato Kigasawa; Yasushi Ishida; Akira Ohara; Ryoji Hanada; Masahiro Sako; Takeyuki Sato; Shuki Mizutani; Keizo Horibe; Eiichi Ishii
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Ying-Wei Lin; K i Watanabe; Keigo Hamahata; Souichi Adachi; Y Akiyama; Ikuya Usami; Masaru Kubota; T Tsutsui; K Shimizu; S Ohta; M Sawada; Toshiyuki Kitoh; A Kataoka; Yoshihiro Wakazono; Tatsutoshi Nakahata
[Childhood t(8;21) acute myelocytic leukemia: a comparison of clinical features and risk factors with adult cases].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshihiro Wakazono (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Katsutsugu Umeda; Makoto Yoshida; Nobuhiro Suzuki; Mikiya Endo; Atsushi Sato; Hiroki Hori; Mitsuharu Isogai; Kimikazu Matsumoto; Jun-iIchi Hara; Daiichiro Hasegawa; Yoshiko Hashii; Kosuke Chayama; Ryousuke Miyaji; Shin-ichiro Nishimura; Akihiko Tanizawa; Ikuya Uami; Keizo Horibe; Yoshihiro Wakazono; Keiko Yagi
[Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2007;48(3):204-11.
2004: Yoshiyuki Kosaka; Katsuyoshi Koh; Naoko Kinukawa; Yoshihiro Wakazono; Keiichi Isoyama; Takanori Oda; Yasuhide Hayashi; Shigeru Ohta; Hiroshi Moritake; Megumi Oda; Yoshihisa Nagatoshi; Hisato Kigasawa; Yasushi Ishida; Akira Ohara; Ryoji Hanada; Masahiro Sako; Takeyuki Sato; Shuki Mizutani; Keizo Horibe; Eiichi Ishii
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Blood 2004;104(12):3527-34.
2001: Ying-Wei Lin; K i Watanabe; Keigo Hamahata; Souichi Adachi; Y Akiyama; Ikuya Usami; Masaru Kubota; T Tsutsui; K Shimizu; S Ohta; M Sawada; Toshiyuki Kitoh; A Kataoka; Yoshihiro Wakazono; Tatsutoshi Nakahata
[Childhood t(8;21) acute myelocytic leukemia: a comparison of clinical features and risk factors with adult cases].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2001;42(1):8-14.
2000: Masaru Kubota; Ying-Wei Lin; Keigo Hamahata; M Sawada; S Koishi; H Hirota; Yoshihiro Wakazono
Cancer chemotherapy and somatic cell mutation.
Mutation research 2000;470(2):93-102.
1998: Yoshihiro Wakazono; A Kataoka; T Fusaoka; K Tunamoto
[Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1998;39(7):499-505.
1998: Masaru Kubota; Yoshihiro Wakazono; Kenshi Furusho
Increased cell killing and mutagenecity by DNA alkylating agents in cells with decreased TTP pools.
Advances in experimental medicine and biology 1998;431():611-6.
1996: Ying-Wei Lin; Masaru Kubota; Yoshihiro Wakazono; H Hirota; Ayumu Okuda; R Bessho; Ikuya Usami; A Kataoka; Chutaro Yamanaka; Y Akiyama; Kenshi Furusho
Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy.
Mutation research 1996;362(1):97-103.
1996: Yoshihiro Wakazono; Masaru Kubota; Kenshi Furusho; L Liu; S L Gerson
Thymidine kinase deficient cells with decreased TTP pools are hypersensitive to DNA alkylating agents.
Mutation research 1996;362(1):119-25.
1995: K Kuwakado; Masaru Kubota; R Bessho; A Kataoka; Ikuya Usami; Ying-Wei Lin; Ayumu Okuda; Yoshihiro Wakazono
Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.
Leukemia research 1995;19(9):645-50.
1995: Masaru Kubota; A Kataoka; Ayumu Okuda; R Bessho; Ying-Wei Lin; Yoshihiro Wakazono; Ikuya Usami; Y Akiyama; Kenshi Furusho
Selection and partial characterization of calcium ionophore (A23187) resistant cells.
Biochemical and biophysical research communications 1995;213(2):541-9.
1995: A Kataoka; Masaru Kubota; Yoshihiro Wakazono; Ayumu Okuda; R Bessho; Ying-Wei Lin; Ikuya Usami; Y Akiyama; Kenshi Furusho
Association of high molecular weight DNA fragmentation with apoptotic or non-apoptotic cell death induced by calcium ionophore.
FEBS letters 1995;364(3):264-7.
1995: H Nakato; Yoshihiro Wakazono; R Bessho; Y Higaki; H Mikawa
[Serum ECP level of infants of atopic dermatitis].
Arerugī = [Allergy] 1995;44(5):540-6.
1994: R Bessho; K Matsubara; Masaru Kubota; K Kuwakado; H Hirota; Yoshihiro Wakazono; Ying-Wei Lin; Ayumu Okuda; M Kawai; R Nishikomori
Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.
Biochemical pharmacology 1994;48(10):1883-9.
1994: S Adachi; Masaru Kubota; Ying-Wei Lin; Ayumu Okuda; K Matsubara; Yoshihiro Wakazono; H Hirota; K Kuwakado; Y Akiyama
In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro.
European journal of haematology 1994;53(3):129-34.
1994: H Hirota; Masaru Kubota; S Adachi; Ayumu Okuda; Ying-Wei Lin; R Bessho; Yoshihiro Wakazono; K Matsubara; K Kuwakado; Y Akiyama
Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.
Mutation research 1994;315(2):95-103.
1994: K Matsubara; Masaru Kubota; K Kuwakado; H Hirota; Yoshihiro Wakazono; Ayumu Okuda; R Bessho; Ying-Wei Lin; S Adachi; Y Akiyama
Variable susceptibility to apoptosis induced by calcium ionophore in hybridomas between HL-60 promyelocytic and CEM T-lymphoblastic leukemia cell lines: relationship to constitutive Mg(2+)-dependent endonuclease.
Experimental cell research 1994;213(2):412-7.
1994: Yoshihiro Wakazono; Masaru Kubota; H Sano; K Matsubara; H Hirota; K Kuwakado; S Adachi
Different effect of thymidine kinase loss on TTP pools; comparison among human leukemia cell lines.
Mutation research 1994;304(2):295-300.
1994: K Matsubara; Masaru Kubota; S Adachi; K Kuwakado; H Hirota; Yoshihiro Wakazono; Y Akiyama; H Mikawa
Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo.
European journal of haematology 1994;52(1):47-52.
1994: K Matsubara; Masaru Kubota; S Adachi; K Kuwakado; H Hirota; Yoshihiro Wakazono; Y Akiyama; H Mikawa
Different mode of cell death induced by calcium ionophore in human leukemia cell lines: possible role of constitutive endonuclease.
Experimental cell research 1994;210(1):19-25.
1993: S Adachi; Masaru Kubota; K Matsubara; Yoshihiro Wakazono; H Hirota; K Kuwakado; Y Akiyama; H Mikawa
Role of protein kinase C in neutrophil survival enhanced by granulocyte colony-stimulating factor.
Experimental hematology 1993;21(13):1709-13.
1993: S Adachi; Masaru Kubota; Yoshihiro Wakazono; H Hirota; K Matsubara; K Kuwakado; Y Akiyama; H Mikawa
Mechanism of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine.
Experimental hematology 1993;21(9):1213-8.